Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers
PositiveFinancial Markets

- Eli Lilly and Johnson & Johnson are partnering with Nvidia to leverage AI technology in drug discovery, reflecting a significant trend in the pharmaceutical industry towards tech collaboration.
- This partnership is expected to streamline operations and improve productivity in healthcare, which is crucial as the demand for innovative treatments rises.
- The collaboration aligns with broader market movements where major tech investments, such as Nvidia's role in AI, are reshaping industries, highlighting the increasing intersection of healthcare and technology.
— via World Pulse Now AI Editorial System







